Trial intelligence / Profile preview

Femoral Nerve Block vs IV Fentanyl for Hip Fracture Pain

NCT06862154Phase 4Completed

Sponsor
Marmara University
Start
Nov 2022
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine hydrochloride 0.75% injection in hip fracture, sponsored by Marmara University. Started Nov 2022; status: completed.

02

Drugs

bupivacaine hydrochloride 0.75% injection
03

Conditions

hip fracture

Beyond the preview

Go deeper on NCT06862154.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06862154.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call